Eun-som Kim

Title: The Innovations of Eun-som Kim

Introduction

Eun-som Kim is a notable inventor based in Seongnam-si, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of vaccines. With a total of 3 patents to his name, his work focuses on enhancing the efficacy and safety of viral vaccines.

Latest Patents

One of his latest patents is titled "Respiratory syncytial virus recombinant F protein and vaccine composition containing same." This invention provides a respiratory syncytial virus (RSV) recombinant fusion protein (F protein) that includes a polymerization domain derived from a foreign protein. This fusion protein is designed to be soluble and capable of retaining an F protein trimer, which is expected to induce excellent immune responses. Another significant patent is "Recombinant RSV live vaccine strain and the preparing method thereof." This invention details a recombinant attenuated RSV that comprises a stabilized pre-fusion F protein. The live vaccine strain maintains infectability while ensuring excellent safety and stability.

Career Highlights

Eun-som Kim is currently associated with Sk Bioscience Co., Ltd., where he continues to innovate in the field of vaccine development. His work has been instrumental in advancing the understanding and treatment of respiratory viruses.

Collaborations

He has collaborated with notable colleagues such as Ki-weon Seo and Teawoo Kwon, contributing to the collective expertise in their research endeavors.

Conclusion

Eun-som Kim's contributions to vaccine technology, particularly in the realm of respiratory syncytial virus, highlight his role as a leading inventor in biotechnology. His innovative patents reflect a commitment to improving public health through advanced vaccine solutions.